Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Melanoma × Injections × Clear all

Phase

Status

Unknown 4 Recruiting 2 Completed 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 11 Recurrence 3 Myelodysplastic Syndromes 3 Leukemia, Myelomonocytic, Chronic 3 Neoplasm Metastasis 2 Lymphoma, B-Cell 2 Leukemia, Monocytic, Acute 2 Breast Neoplasms 2 Advanced Solid Tumors 2 Solid Tumor 1 Small Cell Lung Carcinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Non-Squamous Non-small Cell Lung Cancer 1 Nasopharyngeal Carcinoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Microsatellite Instability 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Basophilic, Acute 1 Leukemia 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 EGFR Positive Non-small Cell Lung Cancer 1

Interventions

pembrolizumab 60 Nivolumab 38 Ipilimumab 25 trametinib 11 Specimen Handling 9 Cyclophosphamide 9 dabrafenib 8 Magnetic Resonance Spectroscopy 8 fludarabine 7 CTLA-4 Antigen 7 encorafenib 6 binimetinib 6 Radiosurgery 6 Interleukin-2 6 Biopsy 6 lenvatinib 5 fludarabine phosphate 5 atezolizumab 5 Radiotherapy 5 Introns 5 Cisplatin 5 durvalumab 4 dostarlimab 4 cobimetinib 4 Pemetrexed 4 Paclitaxel 4 Interferon alpha-2 4 Carboplatin 4 tocilizumab 3 tislelizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04722575 2025-03-13

NEO-TIM

Fondazione Melanoma Onlus

Phase 2 Active not recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡